FDA gives tentative nod for Glenmark’s generic QternQtern tablets, 10 mg/5 mg had a market value of roughly $10.4 million for the 12 months ended February 2020, according to IQVIA. Dr. Reddy's debuts generic DDAVPThe DDAVP (desmopressin acetate) injection brand and generic had a market value of approximately $20.9 million for the most recent 12 months ended March 2020, according to IQVIA. Zydus gets tentative nod for generic Synjardy Zydus Cadila’s generic Synjardy was given tentative approval for four dosage strengths. Aurobindo gets FDA green light for generic Ancobon Flucytosine capsules had a market value of roughly $43 million for the 12 months ended March 2020, according to IQVIA. Hikma debuts generic Buprenex Buprenorphine hydrochloride injection, had a market value of approximately $16 million for the 12 months ended February 2020, according to IQVIA. Teva, Celltrion introduce Rituxan biosimilar Teva and Celltrion's Truxima is the only biosimilar to Rituxan. AAM survey: Pharmaceutical shipping costs spiked due to pandemic AAM's survey reveals a 224% hike, on average, in the cost of transporting drugs. Teva releases new dosage strength for generic Jadenu Teva now offers generic Jadenu in three dosage strengths. Amphastar receives FDA nod for generic Adrenalin Adrenalin has a market value of roughly $131 million for the 12 months ended Dec. 31, 2019, according to IQVIA. Dr. Reddy's debuts generic Tricor The Tricor brand and generic had a market value of roughly $90 million for the 12 months ended January 2020, according to IQVIA. First Previous 142 143 144 145 146 Next Last